These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25721923)

  • 1. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.
    Kostjukovits S; Kalliokoski L; Antila K; Korppi M
    Eur J Pediatr; 2015 Jun; 174(6):707-14. PubMed ID: 25721923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
    Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
    Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report.
    Korppi M; Van Gijn ME; Antila K
    Acta Paediatr; 2011 Jan; 100(1):21-5. PubMed ID: 20712835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
    Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Devlin LA; Edgar JD
    J Clin Rheumatol; 2014 Mar; 20(2):103-5. PubMed ID: 24561416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canakinumab for the treatment of hyperimmunoglobulin D syndrome.
    Sánchez-Manubens J; Iglesias E; Anton J
    Expert Rev Clin Immunol; 2019 Mar; 15(3):215-220. PubMed ID: 30652926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
    Galeotti C; Meinzer U; Quartier P; Rossi-Semerano L; Bader-Meunier B; Pillet P; Koné-Paut I
    Rheumatology (Oxford); 2012 Oct; 51(10):1855-9. PubMed ID: 22740624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.
    Topaloğlu R; Ayaz NA; Waterham HR; Yüce A; Gumruk F; Sanal O
    Clin Rheumatol; 2008 Oct; 27(10):1317-20. PubMed ID: 18506569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review.
    Deshayes S; Georgin-Lavialle S; Hot A; Durel CA; Hachulla E; Rouanes N; Audia S; Le Gallou T; Quartier P; Urbanski G; Messer L; Klein S; de Boysson H; Bienvenu B; Grateau G; Aouba A
    J Rheumatol; 2018 Mar; 45(3):425-429. PubMed ID: 29335349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Walsh D; Edgar JD
    Rheumatol Int; 2012 Jan; 32(1):249-51. PubMed ID: 20020131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.
    Campanilho-Marques R; Brogan PA
    Clin Rheumatol; 2014 Nov; 33(11):1681-4. PubMed ID: 24531849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marketing surveillance in Japan.
    Hosono K; Matsumoto K; Shimbo M; Tsumiyama I; Kato C
    Mod Rheumatol; 2023 Mar; 33(2):381-391. PubMed ID: 35575279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra.
    Peciuliene S; Burnyte B; Gudaitiene R; Rusoniene S; Drazdiene N; Liubsys A; Utkus A
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):19. PubMed ID: 27012807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
    Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
    Rigante D; Ansuini V; Bertoni B; Pugliese AL; Avallone L; Federico G; Stabile A
    Rheumatol Int; 2006 Nov; 27(1):97-100. PubMed ID: 16871408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review.
    Gezgin Yıldırım D; Yıldız Yıldırım Ç; Karaçayır N; Esmeray Şenol P; Sunar Yayla EN; Bakkaloğlu SA
    Clin Rheumatol; 2023 Jan; 42(1):277-283. PubMed ID: 36149537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.